{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:56:13Z","timestamp":1778810173720,"version":"3.51.4"},"reference-count":49,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin intervent Radiol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Historically, the care for patients with vascular anomalies has been challenging due to the complex nature and diversity of these anomalies with a wide array of symptomatology. In the recent past, most therapies for vascular anomalies focused on surgical, procedural, and supportive care measures to treat local symptoms, but many patients still experienced significant disease with excess morbidity and mortality. Today, the pharmacotherapeutic options available for treating vascular anomalies have greatly expanded due to the increased understanding of the genetic and molecular pathways causing these anomalies, with the subsequent development of more targeted pharmacotherapies. In addition to the growth in targeted medications available to treat patients with vascular anomalies, there has been an improved understanding of the hematologic abnormalities related to these diseases and how to manage them. While interventional radiologists do not typically primarily manage systemic medications to treat vascular anomalies, a baseline understanding of the medical management of these diseases is essential to ensuring that a contemporary, multidisciplinary, multimodal approach to treatment is pursued when appropriate. Ultimately, patients are now benefitting from having multiple modalities of treatments available to them and are experiencing improved quality of life and less morbidity.<\/jats:p>","DOI":"10.1055\/s-0044-1791538","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T23:30:16Z","timestamp":1731022216000},"page":"404-412","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Medical Management in Vascular Anomalies"],"prefix":"10.1055","volume":"41","author":[{"given":"Michael H.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Matthew","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Children's Healthcare of Atlanta, Vascular Anomalies Clinic, Atlanta, Georgia"},{"name":"Division of Pediatric Radiology, Department of Radiology and Imaging Sciences, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1055\/s-0037-1604297","article-title":"Advances in the medical management of vascular anomalies","volume":"34","author":"K W Ricci","year":"2017","journal-title":"Semin Intervent Radiol"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0037-1604302","article-title":"Importance of multidisciplinary approach to vascular malformation management","volume":"34","author":"P J Rochon","year":"2017","journal-title":"Semin Intervent Radiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1099328","DOI":"10.3389\/fneur.2023.1099328","article-title":"Vascular malformations: an overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapy","volume":"14","author":"A Mansur","year":"2023","journal-title":"Front Neurol"},{"issue":"11","key":"ref4","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1172\/JCI124649","article-title":"Mosaic RAS\/MAPK variants cause sporadic vascular malformations which respond to targeted therapy","volume":"128","author":"L Al-Olabi","year":"2018","journal-title":"J Clin Invest"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"e2314829","DOI":"10.1001\/jamanetworkopen.2023.14829","article-title":"Barriers to genetic testing in vascular malformations","volume":"6","author":"A J Borst","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress","volume":"40","author":"S Sengupta","year":"2010","journal-title":"Mol Cell"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children","volume":"57","author":"A M Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"e20153257","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"D M Adams","year":"2016","journal-title":"Pediatrics"},{"issue":"08","key":"ref10","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1007\/s00405-022-07378-8","article-title":"Efficacy of sirolimus in children with lymphatic malformations of the head and neck","volume":"279","author":"S Wiegand","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000348327","article-title":"Variable somatic TIE2 mutations in half of sporadic venous malformations","volume":"4","author":"J Soblet","year":"2013","journal-title":"Mol Syndromol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ng.272","article-title":"Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations","volume":"41","author":"N Limaye","year":"2009","journal-title":"Nat Genet"},{"issue":"22","key":"ref13","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1093\/hmg\/ddv349","article-title":"Common and specific effects of TIE2 mutations causing venous malformations","volume":"24","author":"M N\u00e4tynki","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jid.2016.07.034","article-title":"Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations","volume":"137","author":"J Soblet","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ajhg.2015.11.011","article-title":"Somatic activating PIK3CA mutations cause venous malformation","volume":"97","author":"N Limaye","year":"2015","journal-title":"Am J Hum Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pediatrneurol.2021.09.014","article-title":"Prenatal sirolimus treatment for rhabdomyomas in tuberous sclerosis","volume":"125","author":"D Ebrahimi-Fakhari","year":"2021","journal-title":"Pediatr Neurol"},{"issue":"07","key":"ref17","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/pd.5925","article-title":"Fetal therapy using rapamycin for a rapidly enlarging, obstructive, cervical lymphatic malformation: a case report","volume":"41","author":"J Livingston","year":"2021","journal-title":"Prenat Diagn"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/pbc.25241","article-title":"Successful treatment of Kaposiform hemangioendothelioma with everolimus","volume":"62","author":"T Uno","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/pde.13547","article-title":"Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: a case series","volume":"35","author":"S Le Sage","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/lrb.2021.0103","article-title":"Sirolimus in the treatment of microcystic lymphatic malformations: a systematic review","volume":"21","author":"J MC Teng","year":"2023","journal-title":"Lymphat Res Biol"},{"issue":"20","key":"ref21","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer","volume":"380","author":"F Andr\u00e9","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"100969","DOI":"10.1016\/j.gim.2023.100969","article-title":"Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS)","volume":"25","author":"G Canaud","year":"2023","journal-title":"Genet Med"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA","volume":"166","author":"V L Luks","year":"2015","journal-title":"J Pediatr"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s13023-023-02961-6","article-title":"Fibro-adipose vascular anomaly (FAVA) - diagnosis, staging and management","volume":"18","author":"H Wang","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.hoc.2019.01.011","article-title":"Vascular anomalies: diagnosis of complicated anomalies and new medical treatment options","volume":"33","author":"D M Adams","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"579591","DOI":"10.3389\/fped.2020.579591","article-title":"A primer on a comprehensive genetic approach to vascular anomalies","volume":"8","author":"A J Borst","year":"2020","journal-title":"Front Pediatr"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1097\/MPH.0000000000000514","article-title":"Gorham-Stout disease successfully treated with sirolimus and zoledronic acid therapy","volume":"38","author":"S L Cramer","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3748\/wjg.v22.i11.3158","article-title":"Effective treatment of gastrointestinal bleeding with thalidomide -- chances and limitations","volume":"22","author":"J Bauditz","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1053\/j.gastro.2011.07.018","article-title":"Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation","volume":"141","author":"Z Z Ge","year":"2011","journal-title":"Gastroenterology"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"150966","DOI":"10.1016\/j.sempedsurg.2020.150966","article-title":"Coagulation issues in vascular anomalies","volume":"29","author":"K W Ricci","year":"2020","journal-title":"Semin Pediatr Surg"},{"issue":"08","key":"ref32","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/jpc.13461","article-title":"Localised intravascular coagulation complicating venous malformations in children: associations and therapeutic options","volume":"53","author":"K Y Zhuo","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"ref33","author":"M Wille"},{"issue":"07","key":"ref34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1001\/archderm.144.7.873","article-title":"Association of localized intravascular coagulopathy with venous malformations","volume":"144","author":"A Dompmartin","year":"2008","journal-title":"Arch Dermatol"},{"issue":"03","key":"ref35","doi-asserted-by":"crossref","first-page":"102400","DOI":"10.1016\/j.rpth.2024.102400","article-title":"Direct oral anticoagulants and venous malformations: literature review and retrospective study of 29 patients","volume":"8","author":"E Lagneaux","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"05","key":"ref36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/pde.12373","article-title":"Aspirin therapy in venous malformation: a retrospective cohort study of benefits, side effects, and patient experiences","volume":"31","author":"J T Nguyen","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0883073812463607","article-title":"Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes","volume":"28","author":"E I Lance","year":"2013","journal-title":"J Child Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pediatrneurol.2021.02.006","article-title":"Multicenter research data of epilepsy management in patients with Sturge-Weber syndrome","volume":"119","author":"L F Smegal","year":"2021","journal-title":"Pediatr Neurol"},{"issue":"05","key":"ref39","doi-asserted-by":"crossref","first-page":"e29610","DOI":"10.1002\/pbc.29610","article-title":"Coagulopathy and related complications following sclerotherapy of congenital venous malformations","volume":"69","author":"R F Swerdlin","year":"2022","journal-title":"Pediatr Blood Cancer"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2012.06.044","article-title":"Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals","volume":"162","author":"S E Croteau","year":"2013","journal-title":"J Pediatr"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/bjh.13557","article-title":"Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon","volume":"171","author":"C O'Rafferty","year":"2015","journal-title":"Br J Haematol"},{"issue":"05","key":"ref42","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.pcl.2010.07.006","article-title":"Kasabach-Merritt phenomenon","volume":"57","author":"M Kelly","year":"2010","journal-title":"Pediatr Clin North Am"},{"issue":"02","key":"ref43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1525-1470.2008.00626.x","article-title":"Infantile hemangiomas: how common are they? A systematic review of the medical literature","volume":"25","author":"C Kilcline","year":"2008","journal-title":"Pediatr Dermatol"},{"issue":"06","key":"ref45","doi-asserted-by":"crossref","first-page":"e1739","DOI":"10.1542\/peds.2012-3828","article-title":"RCT of timolol maleate gel for superficial infantile hemangiomas in 5- to 24-week-olds","volume":"131","author":"H Chan","year":"2013","journal-title":"Pediatrics"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2340\/00015555-2681","article-title":"The role of topical timolol in the treatment of infantile hemangiomas: a systematic review and meta-analysis","volume":"97","author":"M Khan","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"01","key":"ref47","first-page":"55","article-title":"Infantile hemangioma: an updated review","volume":"17","author":"A KC Leung","year":"2021","journal-title":"Curr Pediatr Rev"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jpedsurg.2013.08.020","article-title":"Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study","volume":"48","author":"M A Malik","year":"2013","journal-title":"J Pediatr Surg"},{"issue":"04","key":"ref49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/jamaoto.2013.6723","article-title":"Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial","volume":"140","author":"N M Bauman","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"06","key":"ref50","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/lary.24363","article-title":"How should propranolol be initiated for infantile hemangiomas: inpatient versus outpatient?","volume":"124","author":"N J Patel","year":"2014","journal-title":"Laryngoscope"},{"key":"ref51","first-page":"86","article-title":"Isolated flat capillary midline lumbosacral hemangiomas as indicators of occult spinal dysraphism","volume":"100","author":"R S Tubbs","year":"2004","journal-title":"J Neurosurg"},{"issue":"03","key":"ref52","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1525-1470.2011.01420.x","article-title":"Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas","volume":"28","author":"K A Horii","year":"2011","journal-title":"Pediatr Dermatol"}],"container-title":["Seminars in Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1791538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T23:31:34Z","timestamp":1731022294000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1791538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":49,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,11,7]]},"published-print":{"date-parts":[[2024,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1791538","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0739-9529","1098-8963"],"issn-type":[{"value":"0739-9529","type":"print"},{"value":"1098-8963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}